vs
Aligos Therapeutics, Inc.（ALGS）与Sintx Technologies, Inc.（SINT）财务数据对比。点击上方公司名可切换其他公司
Sintx Technologies, Inc.的季度营收约是Aligos Therapeutics, Inc.的1.7倍（$290.0K vs $169.0K），Sintx Technologies, Inc.同比增速更快（-46.5% vs -72.1%），过去两年Sintx Technologies, Inc.的营收复合增速更高（-35.0% vs -50.7%）
Aligos Therapeutics是一家临床阶段生物制药企业，专注于开发针对流行性肝病与病毒感染的新型靶向疗法，核心管线覆盖慢性乙型肝炎、非酒精性脂肪性肝炎等适应症，通过自主研发推进药物落地，满足全球未被满足的医疗需求。
Sintx Technologies, Inc.是一家先进材料企业，专注于研发及生产高性能氮化硅与其他特种陶瓷产品，服务医疗植入部件、航空航天、国防、工业耐磨组件、电动汽车等核心领域，市场覆盖北美、欧洲及亚太地区。
ALGS vs SINT — 直观对比
营收规模更大
SINT
是对方的1.7倍
$169.0K
营收增速更快
SINT
高出25.6%
-72.1%
两年增速更快
SINT
近两年复合增速
-50.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $169.0K | $290.0K |
| 净利润 | — | $-2.2M |
| 毛利率 | — | 64.8% |
| 营业利润率 | — | -799.3% |
| 净利率 | — | -763.8% |
| 营收同比 | -72.1% | -46.5% |
| 净利润同比 | 75.8% | -30.7% |
| 每股收益（稀释后） | — | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGSSINT
| Q4 25 | $169.0K | $290.0K | ||
| Q3 25 | $741.0K | $208.0K | ||
| Q2 25 | $965.0K | $151.0K | ||
| Q1 25 | $311.0K | $369.0K | ||
| Q4 24 | $606.0K | $542.0K | ||
| Q3 24 | $1.3M | $799.0K | ||
| Q2 24 | $1.1M | $859.0K | ||
| Q1 24 | $694.0K | $687.0K |
净利润ALGSSINT
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $-31.5M | $-3.5M | ||
| Q2 25 | $-15.9M | $-2.3M | ||
| Q1 25 | $43.1M | $-2.3M | ||
| Q4 24 | $-82.2M | $-1.7M | ||
| Q3 24 | $-19.3M | $-6.2M | ||
| Q2 24 | $5.1M | $-2.2M | ||
| Q1 24 | $-34.9M | $-886.0K |
毛利率ALGSSINT
| Q4 25 | — | 64.8% | ||
| Q3 25 | — | 44.7% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 33.3% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 73.7% | ||
| Q2 24 | — | 73.9% | ||
| Q1 24 | — | 67.5% |
营业利润率ALGSSINT
| Q4 25 | — | -799.3% | ||
| Q3 25 | -3827.4% | -1613.0% | ||
| Q2 25 | -1924.0% | -1764.9% | ||
| Q1 25 | -6187.5% | -645.8% | ||
| Q4 24 | -3393.2% | -319.6% | ||
| Q3 24 | -1610.5% | -802.0% | ||
| Q2 24 | -2489.5% | -315.5% | ||
| Q1 24 | -3176.7% | -465.4% |
净利率ALGSSINT
| Q4 25 | — | -763.8% | ||
| Q3 25 | -4256.0% | -1701.4% | ||
| Q2 25 | -1643.8% | -1535.1% | ||
| Q1 25 | 13854.7% | -621.1% | ||
| Q4 24 | -13556.1% | -312.7% | ||
| Q3 24 | -1540.7% | -780.9% | ||
| Q2 24 | 477.0% | -256.6% | ||
| Q1 24 | -5023.5% | -129.0% |
每股收益（稀释后）ALGSSINT
| Q4 25 | — | $-0.50 | ||
| Q3 25 | $-3.04 | $-3.46 | ||
| Q2 25 | $-1.53 | $-0.91 | ||
| Q1 25 | $-2.11 | $-1.29 | ||
| Q4 24 | $-13.10 | $17.04 | ||
| Q3 24 | $-3.07 | $-6.96 | ||
| Q2 24 | $0.81 | $-3.61 | ||
| Q1 24 | $-5.58 | $-21.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.8M | $4.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $53.5M | $2.9M |
| 总资产 | $88.5M | $9.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALGSSINT
| Q4 25 | $77.8M | $4.1M | ||
| Q3 25 | $99.1M | $6.3M | ||
| Q2 25 | $122.9M | $4.3M | ||
| Q1 25 | $137.9M | $6.5M | ||
| Q4 24 | $56.9M | $3.6M | ||
| Q3 24 | $74.9M | $4.8M | ||
| Q2 24 | $94.5M | $4.6M | ||
| Q1 24 | $112.7M | $5.8M |
股东权益ALGSSINT
| Q4 25 | $53.5M | $2.9M | ||
| Q3 25 | $71.8M | $4.1M | ||
| Q2 25 | $101.9M | $4.0M | ||
| Q1 25 | $116.4M | $6.1M | ||
| Q4 24 | $-29.0M | $3.9M | ||
| Q3 24 | $50.1M | $5.6M | ||
| Q2 24 | $67.2M | $8.8M | ||
| Q1 24 | $59.8M | $9.9M |
总资产ALGSSINT
| Q4 25 | $88.5M | $9.5M | ||
| Q3 25 | $109.8M | $11.4M | ||
| Q2 25 | $134.7M | $9.2M | ||
| Q1 25 | $150.7M | $11.4M | ||
| Q4 24 | $70.1M | $9.4M | ||
| Q3 24 | $88.4M | $11.3M | ||
| Q2 24 | $108.8M | $15.3M | ||
| Q1 24 | $127.9M | $17.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-82.5M | $-2.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.4M |
| 自由现金流率自由现金流/营收 | — | -822.8% |
| 资本支出强度资本支出/营收 | — | 14.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALGSSINT
| Q4 25 | $-82.5M | $-2.3M | ||
| Q3 25 | $-24.3M | $-2.5M | ||
| Q2 25 | $-15.5M | $-2.4M | ||
| Q1 25 | $-20.9M | $-1.3M | ||
| Q4 24 | $-18.4M | $-1.1M | ||
| Q3 24 | $-20.1M | $-2.6M | ||
| Q2 24 | $-19.5M | $-2.2M | ||
| Q1 24 | $-22.7M | $-2.7M |
自由现金流ALGSSINT
| Q4 25 | — | $-2.4M | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-1.4M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $-2.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | — | $-2.9M |
自由现金流率ALGSSINT
| Q4 25 | — | -822.8% | ||
| Q3 25 | — | -1250.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -368.6% | ||
| Q4 24 | — | -234.3% | ||
| Q3 24 | — | -323.0% | ||
| Q2 24 | — | -299.7% | ||
| Q1 24 | — | -423.1% |
资本支出强度ALGSSINT
| Q4 25 | — | 14.5% | ||
| Q3 25 | — | 40.4% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 16.0% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 25.3% |
现金转化率ALGSSINT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.85× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
